Form 4: Ionis Pharmaceuticals Director Allene Diaz Increases Stake Through RSU Vesting

Ionis Pharmaceuticals director Allene M. Diaz acquired 4,079 shares of common stock through the vesting of Restricted Stock Units, increasing her direct beneficial ownership.

Summary

• Allene M. Diaz, a Director of IONIS PHARMACEUTICALS INC (IONS), acquired 4,079 shares of common stock.
• The acquisition occurred on July 15, 2025, and was a result of the vesting and release of shares from a Restricted Stock Unit (RSU) award.
• The transaction price for these shares was $0.0, as it represents an acquisition through vesting rather than a purchase.
• Following this transaction, Ms. Diaz directly beneficially owns 19,795 shares of Ionis common stock.
• Additionally, Ms. Diaz holds 5,220 derivative securities in the form of Restricted Stock Units.
• Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock or its equivalent cash value.
• The RSUs vest 100% on the first anniversary of the grant date or the next regularly scheduled annual meeting of stockholders, whichever is earlier, and are delivered on the July 15th following the vesting date.

Sentiment

Score: 7

Explanation: The sentiment is positive as a director increased their direct beneficial ownership, which is generally seen as a sign of confidence and alignment with shareholder interests.

Positives

• Director Allene M. Diaz increased her direct beneficial ownership of Ionis Pharmaceuticals common stock by 4,079 shares, signaling continued alignment with shareholder interests.
• The acquisition through RSU vesting demonstrates the company's compensation structure is delivering equity to its directors, aligning their incentives with long-term company performance.

Stakeholder Impact

• Shareholders: Increased alignment with the director's interests due to higher direct share ownership, potentially signaling confidence in the company's future.

Key Dates

Keywords

Ionis Pharmaceuticals, IONS, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Director Share Acquisition, Beneficial Ownership, Corporate Governance